Apr 27, 2026 07:00PM
Mar 29, 2018 06:30AM
Mar 28, 2018 07:00PM
Mar 12, 2018 07:00PM
Feb 25, 2018 06:00PM
Feb 18, 2018 06:00PM
Feb 12, 2018 06:30PM MediciNova Announces Closing of Underwritten Public Offering of Common Stock
Feb 7, 2018 07:12PM
Feb 7, 2018 04:01PM
Feb 1, 2018 06:00PM
Jan 31, 2018 07:00AM
Jan 30, 2018 06:02PM
Jan 30, 2018 06:00PM
Jan 28, 2018 06:00PM MediciNova Announces MN-001 (tipelukast) NASH/NAFLD Phase 2 Trial Interim Results Selected for Presentation at the International Liver Congress 2018 in Paris, France
Jan 16, 2018 06:00PM
Dec 7, 2017 06:00PM
Nov 10, 2017 05:55AM
Nov 10, 2017 01:30AM
Nov 9, 2017 06:00PM
Nov 1, 2017 07:00PM
Oct 30, 2017 06:26AM Medicinova (MNOV) Presents Additional Positive Top-Line Results from SPRINT-MS Phase 2b Trial of MN-166 in Progressive MS
Oct 30, 2017 06:00AM
Oct 26, 2017 06:00AM
Sep 19, 2017 06:25AM
Sep 19, 2017 06:00AM
Sep 18, 2017 07:00PM
Aug 30, 2017 06:04AM
Aug 30, 2017 06:00AM MediciNova Announces the Abstract from the MN-166 (ibudilast) SPRINT-MS Phase 2b Study in Progressive MS - including Top Line Data - was Selected as a Platform Presentation for Late-Breaking Presentat
Jun 5, 2017 04:01PM
Jun 5, 2017 04:00PM
Apr 25, 2017 07:00PM
Apr 9, 2017 07:00PM
Feb 27, 2017 06:00PM

323,881 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All